Crossmark

Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy

Crossref DOI link: https://doi.org/10.1186/s12879-019-4648-1

Published Online: 2019-12-09

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kumar, Nathella Pavan http://orcid.org/0000-0002-4901-1507
Moideen, Kadar

Nancy, Arul

Viswanathan, Vijay

Shruthi, Basavaradhya S.

Sivakumar, Shanmugam

Hissar, Syed

Kornfeld, Hardy

Babu, Subash
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-09
More Information

Article History

Received: 28 August 2019

Accepted: 22 November 2019

First Online: 9 December 2019

Ethics approval and consent to participate

: This study was approved by the Ethics Committees of the Prof. M. Viswanathan Diabetes Research Center and NIRT. Informed written consent was obtained from all participants.

: Not applicable” in this section.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below